Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Qom University of Medical Sciences
Iran
Country
Iran
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.muq.ac.ir
Clinical Trials
Related News
Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
Phase 2
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: Doxepin
Drug: placebo
Drug: Nortriptyline
Subscribe
First Posted Date
2010-12-31
Last Posted Date
2010-12-31
Lead Sponsor
Qom University of Medical Sciences
Registration Number
NCT01268709
Locations
🇮🇷
Gastrointestinal Research center,Beheshti Hospital, Qom, Iran, Islamic Republic of
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy